l-DOPA Cytotoxicity to PC12 Cells in Culture Is via Its Autoxidation

Authors

  • Alie N. Basma,

    1. Departments of Pharmacology and Neurology, University of Medicine and Dentistry-Robert Wood Johnson Medical School, Piscataway, New Jersey, U.S.A.
    Search for more papers by this author
    • The present address of A. N. Basma is Ohmeda Incorporated, 100 Mountain Avenue, Murray Hill, NJ 07974, U.S.A.

  • Erick J. Morris,

    1. Departments of Pharmacology and Neurology, University of Medicine and Dentistry-Robert Wood Johnson Medical School, Piscataway, New Jersey, U.S.A.
    Search for more papers by this author
  • William J. Nicklas,

    1. Departments of Pharmacology and Neurology, University of Medicine and Dentistry-Robert Wood Johnson Medical School, Piscataway, New Jersey, U.S.A.
    Search for more papers by this author
  • Herbert M. Geller

    Corresponding author
    1. Departments of Pharmacology and Neurology, University of Medicine and Dentistry-Robert Wood Johnson Medical School, Piscataway, New Jersey, U.S.A.
    Search for more papers by this author

Address correspondence and reprint requests to Dr. H. M. Geller at Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854, U.S.A.

Abstract

Abstract: The mechanism of cytotoxicity of l-DOPA was studied in the rat pheochromocytoma PC12 cell line. The cytotoxicity of l-DOPA to PC12 cells was time and concentration dependent. Carbidopa, which inhibited the conversion of l-DOPA to dopamine, did not protect against l-DOPA cytotoxicity in PC12 cells. Furthermore, clorgyline, a selective inhibitor of monoamine oxidase type A, and pargyline, an inhibitor of both monoamine oxidase types A and B, both did not have an effect on l-DOPA toxicity. These findings suggest that cytotoxicity was not due to dopamine formed from l-DOPA. Catalase or superoxide dismutase each partially protected against l-DOPA toxicity in PC12 cells. In combination, the effects were synergistic and provided almost total protection against cytotoxicity. 6-Cyano-7-nitroquinoxaline-2,3-dione, an antagonist of non-NMDA receptors, did not protect against l-DOPA toxicity. These data suggest that toxicity of l-DOPA is most likely due to the action of free radicals formed as a result of its autoxidation. Furthermore, these findings suggest that patients on long-term l-DOPA therapy are potentially at risk from the toxic intermediates formed as a result of its autoxidation.

Ancillary